Complement activation by apoptotic endothelial cells following hypoxia/reoxygenation

Immunology

Volumn 102, Issue 3, 2001, Pages 359-364

  Mold, C ^a   Morris, C A ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE INHIBITOR; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C3; FLUORESCEIN ISOTHIOCYANATE; LIPOCORTIN 5; OXYGEN; PHOSPHATIDYLSERINE;

APOPTOSIS; ARTICLE; CELL SUBPOPULATION; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYPOXIA; INFLAMMATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REOXYGENATION; REPERFUSION INJURY; UMBILICAL VEIN;

AMINO ACID CHLOROMETHYL KETONES; APOPTOSIS; CASPASES; CELL CULTURE TECHNIQUES; CELL HYPOXIA; COMPLEMENT C3; COMPLEMENT PATHWAY, CLASSICAL; CYSTEINE PROTEINASE INHIBITORS; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOGLOBULIN M; REPERFUSION INJURY;

EID: 0035067266     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2001.01192.x     Document Type: Article

References (23)

1. Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury
2. The complement system in myocardial ischaemia/reperfusion injury
3. Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle
4. Soluble human complement receptor type 1: In vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis
5. Myocardial infarction and apoptosis after myocardial ischemia and reperfusion. Role of the terminal complement components and inhibition by anti-C5 therapy
6. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement
7. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury
8. Complement activation following oxidative stress
9. Complement activation following reoxygenation of hypoxic human endothelial cells: Role of intracellular reactive oxygen species, NF-κB and new protein synthesis
10. A one-step procedure for preparation of classical pathway (C1q) and alternative pathway (factor D) depleted human serum
11. Purification of human complement factor D from the peritoneal fluid of patients on chronic ambulatory peritoneal dialysis
12. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V
13. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
14. Physiology of reactive oxidant-mediated signal transduction: An overview
15. Reoxygenation of hypoxic human umbilical vein endothelial cells activates the classic complement pathway
16. Complement C5a, TGF-β1, and MCP-in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion
17. Role of early reperfusion in the induction of adhesion molecules and cytokines in previously ischemic myocardium
18. Bacterial lipopolysaccharide disrupts endothelial monolayer integrity and survival signaling events through caspase cleavage of adherens junction proteins
19. Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients
20. Complement-dependent clearance of apoptotic cells by human macrophages
21. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes. Complement deficiency and systemic lupus erythematosus revisited
22. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes
23. Antibody-independent activation of C1, the first component of complement, by cardiolipin